Pathways’ Picks February 26: Bundled Payments, Personalized Devices, Diagnostics Reforms

article image

In this week’s Pathways’ Picks: CMS extended its joint implant bundled payment program, Australia considers new ideas for personalized devices, legislation to reform US diagnostics regulations is about to be introduced, and more to watch in diagnostics, clinical trial disclosures, and FDA safety actions.

The US Medicare agency’s next steps on bundled payment programs and Australia’s plans for revamping its approach to personalized and 3D-printed devices are this week’s top Pathways’ Picks. We also spotlight a lot happening in the direction of diagnostics regulatory reform in the US, some interesting updates on clinical trial disclosure requirements, and much more.  

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: